
No. of Pages: 138 | Report Code: TIPRE00014203 | Category: Life Sciences
No. of Pages: 138 | Report Code: TIPRE00014203 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Liposome Drug Delivery Market – By Product
1.3.2 North America Liposome Drug Delivery Market – By Technology
1.3.3 North America Liposome Drug Delivery Market – By Application
1.3.4 North America Liposome Drug Delivery Market – By Geography
2. North America Liposome Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Liposome Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Liposome Drug Delivery Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Liposome Drug Delivery Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market – North America Analysis
6.1 North America Liposome Drug Delivery Market Revenue Forecasts and Analysis
7. North America Liposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product Overview
7.1 North America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)
7.1.1 North America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.2 Liposomal Doxurubicin
7.2.1 Overview
7.2.2 North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
7.3 Liposomal Paclitaxel
7.3.1 North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Liposomal Amphotericin B
7.4.1 overview
7.4.2 North America Liposomal Amphotericin B forecast and market revenue
7.5 Others
7.5.1 overview
7.5.2 North America Other Liposome Drug Delivery Market overview and forecast to 2027
8. North America Liposome Drug Delivery Market – By Technology
8.1 Overview
8.2 North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Liposome Drug Delivery Market – By Application
9.1 Overview
9.2 North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Liposome Drug Delivery Market – Geographic Analysis
10.1 North America: Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 North America: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On North America Liposome Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Takeda Pharmaceutical Company Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.5 Luye Pharma Group
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ipsen Pharma
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. R&D Investments by major pharmaceutical companies
Table 2. North America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 3. North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. List of Abbreviation
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Market Segmentation
Figure 2. North America Liposome Drug Delivery Segmentation : By Region
Figure 3. North America Liposome Drug Delivery Market Overview;
Figure 4. Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period.
Figure 6. Liposome Drug Delivery Market - North America PEST Analysis
Figure 7. North America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 8. North America Liposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)
Figure 10. North America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Liposomal Amphotericin B market revenue and forecast to 2027
Figure 13. North America Other Liposome Drug Delivery Market overview and forecast to 2027
Figure 14. North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
Figure 15. North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
Figure 20. Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. North America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 27. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 28. US: Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic In North American Country Markets
The List of Companies - North America Liposome Drug Delivery Market